Low-Dose 6-Bromoindirubin-3′-Oxime Induces Partial Dedifferentiation of Endothelial Cells to Promote Increased Neovascularization

Stem Cells - United States
doi 10.1002/stem.1658
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

6-Bromoindirubin-3′oxime (BIO) Decreases Proliferation and Migration of Canine Melanoma Cell Lines

Veterinary Journal
Animal ScienceZoologyVeterinary
2015English

GSK3 Inhibitors CHIR99021 and 6-Bromoindirubin-3′-Oxime Inhibit microRNA Maturation in Mouse Embryonic Stem Cells

Scientific Reports
Multidisciplinary
2015English

Delayed Treatment of 6-Bromoindirubin-3′-Oxime Stimulates Neurogenesis and Functional Recovery After Focal Ischemic Stroke in Mice

International Journal of Developmental Neuroscience
Developmental NeuroscienceDevelopmental Biology
2017English

7-Bromoindirubin-3′-Oxime Uncovers a Serine Protease-Mediated Paradigm of Necrotic Cell Death

Biochemical Pharmacology
BiochemistryPharmacology
2008English

6-Bromoindirubin-3′-Oxime (6BIO) Suppresses the mTOR Pathway, Promotes Autophagy, and Exerts Anti-Aging Effects in Rodent Liver

Frontiers in Pharmacology
Pharmacology
2019English

Injury Induces Dedifferentiation of Smooth Muscle Cells and Increased Matrix-Degrading Metalloproteinase Activity in Human Saphenous Vein

Arteriosclerosis, Thrombosis, and Vascular Biology
Cardiovascular MedicineCardiology
2001English

Oxidized Low-Density Lipoprotein Induces Apoptosis in Endothelial Progenitor Cells by Inactivating the Phosphoinositide 3-Kinase/Akt Pathway

Journal of Vascular Research
Cardiovascular MedicinePhysiologyCardiology
2010English

6-Hydroxydopamine Induces Brain Vascular Endothelial Inflammation

IUBMB Life
BiochemistryGeneticsClinical BiochemistryCell BiologyMolecular Biology
2017English

Correction To: Engineered M13 Nanofiber Accelerates Ischemic Neovascularization by Enhancing Endothelial Progenitor Cells

Tissue Engineering and Regenerative Medicine
MedicineBiomedical Engineering
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy